A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

Study identifier:4522IL/0088

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase III Study Measuring Effects on Intima Media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR)

Medical condition

Hypercholesteremia

Phase

Phase 3

Healthy volunteers

No

Study drug

Rosuvastatin calcium

Sex

All

Actual Enrollment

840

Study type

Interventional

Age

45 Years - 70 Years

Date

Study Start Date: 01 Aug 2002
Primary Completion Date: 01 May 2006
Study Completion Date: 01 May 2006

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Other

Verification:

Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria